Literature DB >> 11305464

Predisposing factors and outcome of Staphylococcus aureus bacteremia in neutropenic patients with cancer.

E González-Barca1, J Carratalà, A Mykietiuk, A Fernández-Sevilla, F Gudiol.   

Abstract

Staphylococcus aureus caused 30 of 438 (7%) cases of bacteremia in neutropenic patients with cancer during a 10-year study period. Acute leukemia as an underlying disease and severe oral mucositis were more frequent among patients with Staphylococcus aureus bacteremia (57% vs. 33%, P = 0.01, and 32% vs. 12%, P = 0.006, respectively) than among the 151 patients who had gram-negative bacteremia during the same study period. The most frequent source of Staphylococcus aureus bacteremia was the venous catheter (35% vs. 1%; P = 0.00001). Septic metastases were more frequent in patients with Staphylococcus aureus bacteremia (14% vs. 4%, P = 0.03). Attributable mortality was 10% and overall mortality 23%. Staphylococcus aureus bacteremia remains a significant cause of morbidity and mortality in neutropenic patients with cancer.

Entities:  

Mesh:

Year:  2001        PMID: 11305464     DOI: 10.1007/pl00011241

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

1.  Impact of neutropenia on the clinical outcomes of Staphylococcus aureus bacteremia in patients with hematologic malignancies: a 10-year experience in a tertiary care hospital.

Authors:  Byung-Han Ryu; Seung Cheol Lee; Minjeong Kim; Yewon Eom; Jiwon Jung; Min Jae Kim; Heungsup Sung; Mi-Na Kim; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Jun Hee Woo; Yang Soo Kim; Yong Pil Chong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-10       Impact factor: 3.267

2.  Bloodstream infection caused by S. aureus in patients with cancer: a 10-year longitudinal single-center study.

Authors:  Omar Yaxmehen Bello-Chavolla; Jessica Paola Bahena-Lopez; Pamela Garciadiego-Fosass; Patricia Volkow; Alejandro Garcia-Horton; Consuelo Velazquez-Acosta; Diana Vilar-Compte
Journal:  Support Care Cancer       Date:  2018-06-08       Impact factor: 3.603

3.  IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice.

Authors:  John S Cho; Eric M Pietras; Nairy C Garcia; Romela Irene Ramos; David M Farzam; Holly R Monroe; Julie E Magorien; Andrew Blauvelt; Jay K Kolls; Ambrose L Cheung; Genhong Cheng; Robert L Modlin; Lloyd S Miller
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

Review 4.  Innate and adaptive immune responses against Staphylococcus aureus skin infections.

Authors:  Sheila Krishna; Lloyd S Miller
Journal:  Semin Immunopathol       Date:  2011-11-06       Impact factor: 9.623

5.  Collaborative Interferon-γ and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus.

Authors:  Jobert G Barin; Monica V Talor; Julie A Schaub; Nicola L Diny; Xuezhou Hou; Matthew Hoyer; Nathan K Archer; Elizabeth S Gebremariam; Meghan F Davis; Lloyd S Miller; Noel R Rose; Daniela Čiháková
Journal:  Am J Pathol       Date:  2016-07-26       Impact factor: 4.307

6.  Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center.

Authors:  Sminil N Mahajan; Jharna N Shah; Ray Hachem; Frank Tverdek; Javier A Adachi; Victor Mulanovich; Kenneth V Rolston; Issam I Raad; Roy F Chemaly
Journal:  Oncologist       Date:  2012-06-15

7.  Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infection.

Authors:  Sabine Rauch; Portia Gough; Hwan Keun Kim; Olaf Schneewind; Dominique Missiakas
Journal:  Infect Immun       Date:  2014-09-02       Impact factor: 3.441

8.  Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages.

Authors:  Federico Pea; Pierluigi Viale; Anna Candoni; Federica Pavan; Leonardo Pagani; Daniela Damiani; Marco Casini; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

9.  Retinoid agonist Am80-enhanced neutrophil bactericidal activity arising from granulopoiesis in vitro and in a neutropenic mouse model.

Authors:  Wanjing Ding; Hiroyuki Shimada; Lin Li; Rahul Mittal; Xiaokun Zhang; Koichi Shudo; Qiaojun He; Nemani V Prasadarao; Lingtao Wu
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

10.  Genetic variation among methicillin-resistant Staphylococcus aureus isolates from cancer patients in Saudi Arabia.

Authors:  M A Alreshidi; A A Alsalamah; R A Hamat; V Neela; A S Alshrari; S S Atshan; H H Alajlan; M Nor Shamsudin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-15       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.